Clara Campàs, PhD

Managing partner and co-founder

Managing partner and co-founder of Asabys. Clara currently serves on the board of directors of Ona Therapeutics, Origo Biopharma, Sidekick Health and Nuage Therapeutics.

Formerly, Clara served as Strategy & Development Director at Kern Pharma and held several positions at Advancell, including being the managing director. Clara has served as a member of the Investment Committee of the venture capital firm HealthEquity (2015-2018), as well as vice-president of CataloniaBIO (2014-2017) and member of the Board of Directors of Biocat (2015-2017).

Clara received her Doctorate in Pharmacy in 2004 and a Master’s in Pharmacy from the University of Barcelona in 1999.



Founder of Asabys Partners

Formerly at Kern Pharma, Healthequity, Advancell

Mentor at CaixaImpulse and Barcelona Mentoring Program, Member of the Board of Directors of CataloniaBIO and Biocat, Business Board of CRG

PhD in Pharmacy Biochemistry and Molecular Biology, Universitat de Barcelona